Proceedings

Day 2 - Wednesday, October 9, 2002

WeOA
Advances in Microfluidics Technology

WeOB
The Value of the Corporate Compund Collection: Protecting Your Investment

The Changing Functionality of Pharmaceutical Compund Repositories

Studies on Compound Stability in DMSO Under Different Conditions

Roundtable Discussion 4

WeOC
Vendor/Exhibitor Session:
Mass Spectrometry and Data Management

Ultraflex TOF/TOF

A Systems Approach to Proteomics Solutions

An Automated Orthogonal Control System for ESI-MS

Recent Pharmaceutical LC-MS Applications Using Tandem Quadrupole and Time-of-Flight Technology

Mass Spectrometry Advances at Thermo Finnigan

Streamlining Metabolite Identification and Quantification with a Hybrid Linear Quadrupole Ion Trap

DMPK Services from Discovery to Clinical

Addressing Higher Throughput Mass Spectrometry Tool in the Palindrome Year

Structural Awareness Spanning All Aspects of Instrumental Analysis in Pharmaceutical R&D

NuGenesis SDMS: A Lab to Enterprise Data Storage, Retrieval and Transfer Solution

Enterprise-Wide Management of Spectral Data

Managing the Data Mountain in In vitro Studies

Archiving Electronic Records to Enhance Compliance with 21CFR Part 11

Roundtable Discussion 5

WeOD
Preclinical Lead Optimization: Are We Making a Difference?

Metabolism Dependent Drug-Drug Interactions

The Rat: A Model for Higher Throughput Evaluation of Oral Absorption

Influencing Chemists to Minimize Attrition

New Strategies and Methodologies for Rapid Analytical Method Development in Support of Lead Optimization

Roundtable Discussion 6

WeOE
Emerging Technologies for Drug Discovery and Development

Desorption/Ionization on Silicon Mass Spectrometry (DIOS/MS) for High Throughput Lead Discovery and Optimization

Emerging Approaches to Data Integration and Bioinformatics in Toxicology and Disease Studies